ArticleVaccines2022

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein.

Francesco Manfredi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.